CLASS ACTION UPDATE for KLIC, PRTA, and SYMC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP
Jul. 09, 2018
NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court; further details about the cases can be found at the links provided.
Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC)Class Period: November 16, 2017 - May 10, 2018Lead Plaintiff Deadline: July 10, 2018
During the class period, Kulicke and Soffa Industries, Inc.'s consolidated financial statements for the fiscal year ending September 30, 2017 could no longer be relied upon due to misstated warranty accruals; and as a result, Defendants' public statements were materially false and misleading at all relevant times.
To learn more go to: http://www.zlk.com/pslra-d/kulicke-and-soffa-industries-inc?wire=3.
Prothena Corporation (NASDAQ:PRTA)Class Period: October 15, 2015 - April 20, 2018Lead Plaintiff Deadline: July 16, 2018
According to the complaint, Prothena allegedly made materially false and/or misleading statements and/or failed to disclose that: relevant trial data showed that Prothena’s antibody NEOD001, designed to treat amyloid light chain amyloidosis (“AL amyloidosis”), was not an effective treatment; the Company made misleading comparisons of NEOD001’s “best response” rates against certain prior studies; and the Company touted Prothena’s ongoing Phase 1/2 study of NEOD001 as providing a strong basis for late-stage Phase 2b and Phase 3 studies of NEOD001, even though the full Phase 1/2 study data demonstrated that NEOD001 was not an effective treatment.
To learn more go to: http://www.zlk.com/pslra-d/prothena-corporation?wire=3.
Symantec Corp. (NASDAQ:SYMC)Class Period: May 20, 2017 - May 10, 2018Lead Plaintiff Deadline: July 16, 2018
The complaint alleges that Symantec's internal controls over financial reporting were materially weak and deficient; Symantec's later disclosed "reporting of certain Non-GAAP measures including those that could impact executive compensation programs" would lead to heightened regulatory scrutiny by the SEC; and as a result, Symantec's public statements were materially false and misleading at all relevant times. On May 10, 2018, Symantec announced the commencement of an internal investigation “in connection with concerns raised by a former employee.”
To learn more go to: http://www.zlk.com/pslra-d/symantec-corp?wire=3.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com